Article
Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trial.
HIV clinical trials - 1 Jan 2000
Rodriguez-Torres Maribel, Slim Jihad, Bhatti Laveeza, Sterling Richard, Sulkowski Mark, Hassanein Tarek, Serrão Rosário, Sola Ricard, Bertasso Anne, Passe And Sharon, Stancic Saray
Abstract excerpt
BACKGROUND: The safety and efficacy of weight-based ribavirin (RBV) dosing regimens in patients with HIV-HCV coinfection has not been demonstrated in randomized clinical trials. OBJECTIVE: This randomized, double-blind, international, parallel-group study in specialist outpatient clinics in the United States, Spain, and Portugal compares the efficacy and safety of 2 RBV dose regimens (800 mg/day and 1000/1200...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.